Welby launches three more apps for pharmas J & J, UCB, and Nippon Shinyaku

Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson& Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company  Nippon Shinyaku, and an app for rheumatoid arthritis patients with UCB Japan.
Source: mobihealthnews - Category: Information Technology Source Type: news